|
RGPD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.11459968926897E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.25599539049881E-11 |
| Normal-vs-Stage2 |
4.256300E-03 |
| Normal-vs-Stage3 |
2.239100E-04 |
| Normal-vs-Stage4 |
7.996100E-04 |
| Stage1-vs-Stage2 |
2.739200E-01 |
| Stage1-vs-Stage3 |
2.278800E-01 |
| Stage1-vs-Stage4 |
5.766400E-01 |
| Stage2-vs-Stage3 |
9.640400E-01 |
| Stage2-vs-Stage4 |
8.422600E-01 |
| Stage3-vs-Stage4 |
8.477600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.1803003019395E-10 |
| Normal-vs-AfricanAmerican |
1.03209999990916E-07 |
| Normal-vs-Asian |
4.595500E-02 |
| Caucasian-vs-AfricanAmerican |
6.682400E-01 |
| Caucasian-vs-Asian |
2.809600E-01 |
| AfricanAmerican-vs-Asian |
3.935600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.93014526373281E-12 |
| Normal-vs-Female |
5.178600E-04 |
| Male-vs-Female |
5.441800E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.75479999997563E-06 |
| Normal-vs-Extreme_Weight |
7.81497089263894E-12 |
| Normal-vs-Obese |
1.07120000003569E-06 |
| Normal-vs-Extreme_Obese |
1.2178999997392E-07 |
| Normal_Weight-vs-Extreme_Weight |
1.104840E-01 |
| Normal_Weight-vs-Obese |
4.665800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.451390E-01 |
| Extreme_Weight-vs-Obese |
5.457200E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.198600E-01 |
| Obese-vs-Extreme_Obese |
2.423800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.188400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.53020000506865E-08 |
| Normal-vs-Age(61-80Yrs) |
8.64830429492258E-12 |
| Normal-vs-Age(81-100Yrs) |
4.34770000001805E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.903900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.037200E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.681500E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.013600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.376000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.441800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.88700183151514E-11 |
| Normal-VS-Type2 PRCC |
1.87600046608338E-10 |
| Normal-VS-KIRP CIMP |
3.175000E-01 |
| Normal-VS-Unclassified PRCC |
8.973700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
7.946000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.86720000017182E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.195350E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.62840000001086E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
8.797800E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.579800E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.27009514017118E-11 |
| Normal-vs-N1 |
2.280500E-02 |
| Normal-vs-N2 |
4.878600E-03 |
| N0-vs-N1 |
1.291710E-02 |
| N0-vs-N2 |
5.885800E-01 |
| N1-vs-N2 |
4.493800E-01 |
|
|
